Az emésztôrendszer védelme cardiovascularis betegségekben

Translated title of the contribution: Protection of gastrointestinal system in cardiovascular diseases

Research output: Contribution to journalArticle

Abstract

Cardiovascular preventive drugs (nonsteroidal antiinflammatory drugs, aspirin, inhibitors of platelet aggregation, anticoagulants) are among the most frequently used medicines all over the world. Gastrointestinal (GI) complications (hemorrhage, ulceration, perphoration) are among the most frequent side effects of these drugs, however, differences in their pharmacodynamics properties and other pleiotropic effects may substantially modify these unwanted events. Authors, based on international and Hungarian guidelines, summarize the most important data for GI protection, focusing on the use of H-2 receptor blockers and proton pump inhibitors.

Original languageHungarian
Pages (from-to)87-96
Number of pages10
JournalLege Artis Medicinae
Volume25
Issue number3
Publication statusPublished - 2015

Fingerprint

Computer Security
Cardiovascular Agents
Gastrointestinal Hemorrhage
Proton Pump Inhibitors
Platelet Aggregation Inhibitors
Drug-Related Side Effects and Adverse Reactions
Anticoagulants
Aspirin
Anti-Inflammatory Agents
Cardiovascular Diseases
Guidelines
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Az emésztôrendszer védelme cardiovascularis betegségekben. / Farsang, C.; Tulassay, Z.

In: Lege Artis Medicinae, Vol. 25, No. 3, 2015, p. 87-96.

Research output: Contribution to journalArticle

@article{e02e5f5cad294429b36c31ab57966a93,
title = "Az em{\'e}szt{\^o}rendszer v{\'e}delme cardiovascularis betegs{\'e}gekben",
abstract = "Cardiovascular preventive drugs (nonsteroidal antiinflammatory drugs, aspirin, inhibitors of platelet aggregation, anticoagulants) are among the most frequently used medicines all over the world. Gastrointestinal (GI) complications (hemorrhage, ulceration, perphoration) are among the most frequent side effects of these drugs, however, differences in their pharmacodynamics properties and other pleiotropic effects may substantially modify these unwanted events. Authors, based on international and Hungarian guidelines, summarize the most important data for GI protection, focusing on the use of H-2 receptor blockers and proton pump inhibitors.",
keywords = "Gastrointestinal protection, Nonsteroidal antiinflammatory drugs, Pleiotrop effect",
author = "C. Farsang and Z. Tulassay",
year = "2015",
language = "Hungarian",
volume = "25",
pages = "87--96",
journal = "Lege Artis Medicinae",
issn = "0866-4811",
publisher = "Literatura Medica Publishing House",
number = "3",

}

TY - JOUR

T1 - Az emésztôrendszer védelme cardiovascularis betegségekben

AU - Farsang, C.

AU - Tulassay, Z.

PY - 2015

Y1 - 2015

N2 - Cardiovascular preventive drugs (nonsteroidal antiinflammatory drugs, aspirin, inhibitors of platelet aggregation, anticoagulants) are among the most frequently used medicines all over the world. Gastrointestinal (GI) complications (hemorrhage, ulceration, perphoration) are among the most frequent side effects of these drugs, however, differences in their pharmacodynamics properties and other pleiotropic effects may substantially modify these unwanted events. Authors, based on international and Hungarian guidelines, summarize the most important data for GI protection, focusing on the use of H-2 receptor blockers and proton pump inhibitors.

AB - Cardiovascular preventive drugs (nonsteroidal antiinflammatory drugs, aspirin, inhibitors of platelet aggregation, anticoagulants) are among the most frequently used medicines all over the world. Gastrointestinal (GI) complications (hemorrhage, ulceration, perphoration) are among the most frequent side effects of these drugs, however, differences in their pharmacodynamics properties and other pleiotropic effects may substantially modify these unwanted events. Authors, based on international and Hungarian guidelines, summarize the most important data for GI protection, focusing on the use of H-2 receptor blockers and proton pump inhibitors.

KW - Gastrointestinal protection

KW - Nonsteroidal antiinflammatory drugs

KW - Pleiotrop effect

UR - http://www.scopus.com/inward/record.url?scp=84928569004&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928569004&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84928569004

VL - 25

SP - 87

EP - 96

JO - Lege Artis Medicinae

JF - Lege Artis Medicinae

SN - 0866-4811

IS - 3

ER -